共 213 条
[1]
Greenblatt MB(2013)The immune pathogenesis of scleroderma: context is everything Curr Rheumatol Rep 15 297-549
[2]
Aliprantis AO(2011)Role of IL-13 in systemic sclerosis Cytokine 56 544-490
[3]
Fuschiotti P(2005)IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 479-2987
[4]
Schmitz J(2002)Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface Eur J Immunol 32 2979-160
[5]
Owyang A(2010)IL-33 and IL-33 receptors in host defense and diseases Allergol Int 59 143-2786
[6]
Oldham E(2007)IL-33 is a chemoattractant for human Th2 cells Eur J Immunol 37 2779-594
[7]
Song Y(2004)Fibrotic disease and the T(H)1/T(H)2 paradigm Nat Rev Immunol 4 583-332
[8]
Murphy E(1997)Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis J Rheumatol 24 328-72
[9]
McClanahan TK(1992)Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma Arthritis Rheum 35 67-1758
[10]
Zurawski G(1997)Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis Am J Pathol 151 1751-1535